Home 2015
Archives
2015 MOC Program Expected to Cost $5.7 Billion Over 10 Years
Time costs account for 90 percent of maintenance of certification costs, estimated at $5.1 billion
Early Invasive Strategy No Benefit 10 Years After NSTE-ACS
No improved outcomes versus selective invasive strategy in non-ST segment acute coronary syndrome
RAPID Score Validated for Prognosis of Pleural Infections
Recently developed score is valid for identifying mortality risk through five years in diverse cohort
Novel Microendoscope Ups Accuracy of Esophageal Screening
Low-cost HRME ups accuracy of Lugol's chromoendoscopy for esophageal cancer
Low Incidence of Diabetic Ketoacidosis With Canagliflozin
Canagliflozin-treated patients with type 2 diabetes have low incidence of serious adverse DKA events
No Significant Pregnancy Risks for Topical Retinoid Exposure
No significantly increased risk of major congenital malformations, spontaneous abortion, prematurity
Early Surgery Tied to Increased Mortality in Polytraumatized
High mortality rates in patients with concomitant severe thoracic trauma and low initial Hb
Outcomes Equal for Continuous, Intermittent β-Lactams in Sepsis
No differences in ICU-free days, 90-day survival, organ failure-free days, bacteremia duration
New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials
Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily
No Lasting Value for Minimally Invasive Lumbar Laminotomy
No differences or improvement in back or leg pain, ODI, neurogenic symptoms, SF-36 scores
